Director or Officer Departures, Elections, Appointments, and Compensation Arrangements

Trulieve Cannabis Corp. 8-K Summary

Business Context and Reporting Period

This Form 8-K Current Report, dated August 27, 2025, discloses significant changes to the executive leadership and Board of Directors of Trulieve Cannabis Corp. The filing addresses the appointment of a new Chief Financial Officer and a new Board member, effective in late August and early September 2025.

Key Financial Metrics

The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel appointments and associated compensation arrangements.

Material Changes

  • Board Appointment: Matthew Foulston was appointed to the Board of Directors on August 27, 2025. He brings experience as a former CFO for Covetrus Inc., TreeHouse Foods Inc., and Compass Minerals International Inc.
  • CFO Appointment: Jan Reese was appointed Chief Financial Officer, effective September 8, 2025. He succeeds Ryan Blust, who will step down from the Interim CFO role but remain as Vice President, Finance.
  • Compensation Structure: Mr. Reese's employment agreement includes an annual base salary of $475,000 and a target annual bonus of $380,000. The agreement also outlines specific severance provisions.

Outlook, Risks, and Contingencies

The filing details significant financial contingencies related to Mr. Reese's employment agreement:

  • Standard Severance: In the event of termination without Cause or resignation for Good Reason, Mr. Reese is entitled to 2x base salary plus the greater of the target or prior actual bonus, paid over 24 months, plus 24 months of COBRA coverage and immediate vesting of unvested equity awards.
  • Change of Control Severance: If termination occurs within 24 months of a Change of Control, the severance multiplier increases to 2.5x base salary plus bonus, payable as a lump sum, with 24 months of COBRA coverage.

Investor Verification Checklist

  • Verify the effective date of Jan Reese's tenure as CFO (September 8, 2025) and the transition plan from Interim CFO Ryan Blust.
  • Review the specific performance goals for Mr. Reese's $380,000 target bonus as established by the Compensation Committee.
  • Confirm the total potential liability for severance payments under the "Change of Control" scenario (2.5x multiplier).
  • Check the Definitive Proxy Statement on Schedule 14A filed on April 29, 2025, for details on the Company's general employee benefit plans referenced in the agreement.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.